chartexchange

Celldex’s anti-KIT antibody meets endpoints in two Phase III CSU trials

Clinical Trials Arena | Sep 22, 2026 10:36 AM EDT

Before the CSU win, Celldex recently terminated the anti-KIT antibody’s separate development in PN.
The post Celldex’s anti-KIT antibody meets endpoints in two Phase III CSU trials appeared first on Clinical Trials Arena .

Read original article